Has Roche Migai withdrawn from the China market?

Quit. Roche Migai withdrew from China market. 20/kloc-In May, 2006, Tailing Pharmaceutical announced that it had reached an agreement with Novartis Pharmaceutical to acquire the orthopedic brand "Migai" and related intellectual property rights, licenses and other assets from the latter, with a transaction amount of $654.38+45 million. Tailing Pharmaceutical will gain sales networks in China (including Hongkong and Taiwan Province), South Korea, Southeast Asia, India and other major Asia-Pacific regions, as well as Switzerland, Australia, Russia, Brazil, South Africa and other regions.